The NIH reports that several long-term COVID treatment trials are progressing.

Published Date: 01 Aug 2023

NIH opens registration for phase 2 clinical trials that will assess at least four potential long COVID treatments. At least seven additional treatments will likely undergo additional clinical trials.

Read Full News

Latest News

Adjunctive Tirofiban Gains Ground in Stroke

Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.

Nestle and Danone Face Fresh Scrutiny Over Infant Formula Recalls

Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public ⁠media...

Spanish Authorities Say Homeopathy Is No Better Than Placebo

Authorities report that stronger trial methodology consistently reduces the apparent benefits linked to homeopathic products across conditions.

Declare Climate Change a Public Health Emergency, EU Experts

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

Certain Gut-Brain Symptoms Transcend Anatomic Divisions

An expanded symptom questionnaire identified 10 gastrointestinal symptom clusters in patients with disorders of gut-brain interaction.

Ebola Deaths in Eastern Congo Rise to 131, WHO Voices Deep Concern

Twenty-six more suspected Ebola deaths were recorded in 24 hours in eastern Democratic Republic of Congo, authorities said on Tuesday, and the head of the World Health...

Todays Updates

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

A nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Todays Updates

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

A nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Latest News

Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.

Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public ⁠media...

Authorities report that stronger trial methodology consistently reduces the apparent benefits linked to homeopathic products across conditions.

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

An expanded symptom questionnaire identified 10 gastrointestinal symptom clusters in patients with disorders of gut-brain interaction.

Twenty-six more suspected Ebola deaths were recorded in 24 hours in eastern Democratic Republic of Congo, authorities said on Tuesday, and the head of the World Health...

News All Time

Balanced Fluid: No Renal Benefit Over Saline in Septic Shock

In children with septic shock, choosing balanced fluid over saline does not appear to change short-term kidney outcomes or survival.

Is Telemedicine Comparable to In-Person Neurology Care?

Virtual neurology care for new patients is comparable to in-person care, with similar 90-day follow-up rates, ED visits, and hospitalizations, a new study shows.

Regenxbio Shares Sink as Safety Concerns Overshadow Muscle Disorder Therapy Trial Win

Regenxbio said on Thursday that its experimental gene therapy for a muscle-wasting disorder met the main goal ⁠in a late-stage study, but its shares plunged 31% in morning...

US Drug Overdose Deaths Dropped for Third Straight Year in 2025, CDC Data Shows

Drug overdose deaths in the United States fell nearly ⁠14% in 2025, federal estimates showed on Wednesday, marking a third ⁠consecutive year of declines.

Common Practice of DOAC Switching After Stroke Challenged

A multicenter, registry-based cohort study showed no short-term benefit of the common practice of switching anticoagulants after a breakthrough ischemic stroke in patients with atrial fibrillation.

Resistant Gut Bacteria May Flag C difficile Infection Risk

Adults colonised with extended-spectrum beta-lactamase-producing bacteria in the intestinal tract may face higher odds of developing Clostridioides difficile infection.

High-Risk Mental Health Patients Left Unmonitored in A&E

A 3-year RCEM programme finds high-risk mental health patients in emergency departments are going unmonitored — though rates have improved significantly since 2023.

Scotland Clears New Bladder Cancer Combination Therapy

The Scottish Medicines Consortium has approved a new first-line combination therapy for restricted use in adults with unresectable or metastatic urothelial cancer.

Acute Extremity Pain in Patient With Cogan's Syndrome Signals Vascular Ischemia

Timely imaging, anticoagulation, and specialist consultations prevented loss of life or limb

Oregon Emergency Physicians Claim Win Against For-Profit Replacements

— Physicians sued their employer over plans to replace them with an out-of-state firm

Advancing Care for Uncomplicated UTIs: Evidence, Equity, and Evolving Treatments

Advancing Care for Uncomplicated UTIs: Evidence, Equity, and Evolving Treatments

HI-PEITHO Kicks Off 'Golden Era' in Pulmonary Embolism

Trial of ultrasound-based, catheter-directed thrombolysis is one of several anticipated studies

We Have a Substance Use Prevention Problem

Having kids hear from people with lived experience can help move the needle

Here's What People Want on 'The Pitt' Season 3

Attention writers on "The Pitt": our audience has suggestions

He Suddenly Couldn't Speak in Space. Astronaut Says Medical Scare Remains a Mystery.

Doctors have ruled out a heart attack

'Bob's Burgers' Actor Hospitalized; COVID Vax Trial Halted; Utah Measles Cases Rise

Health news and commentary gathered by MedPage Today staff

Recommended News For You

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.

Inner Thoughts of Leonard Bernstein, the "Maestro".

Recommended Articles For You

The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring 

Exosomes in Cancer: A Novel Frontier for Therapy and Biomarker Discovery 

Exploring the Latest Treatments for Essential Thrombocythemia 

Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

2.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

3.

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

4.

According to a study, taking part in a clinical trial for cancer may not actually increase survival.

5.

A new blood test greatly increases the ability to detect cancer.

1.

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis

2.

Unraveling the Mysteries of Hematocrit: How It Impacts Your Health

3.

The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers

4.

Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer

5.

Surprising Symptoms of Prostate Cancer: What You Need to Know

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part X

2.

Efficient Management of First line ALK-rearranged NSCLC - Part III

3.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

4.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

5.

Updates on Standard V/S High Risk Myeloma Treatment- The Next Part

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot